Stress, sleep and the things that quietly kill desire

What actually decides this outcome, in order of size

Desire is a permissive system: it is switched off by conditions rather than switched on by molecules. Ranked by how often each one turns out to be the whole answer:

1. The repeat prescription, which is first because it is the largest and the least suspected. A prospective study of 1,022 outpatients on antidepressants found sexual dysfunction in 59.1% overall, with wide separation between agents: 72.7% on citalopram and 70.7% on paroxetine against 24.4% on mirtazapine and 8% on nefazodone Montejo 2001. Nothing on this shelf competes with a drug that is producing the effect in seven readers out of ten.
2. Sleep, both the quantity and the breathing, and both change testosterone. One week of sleep restricted to five hours a night lowered daytime testosterone in young healthy men Leproult 2011, and obstructive sleep apnea is estimated at 936 million adults worldwide aged 30 to 69 Benjafield 2019. The second one is invisible to every test on this page and is treated by a machine rather than by a capsule, over 936 million adults worldwide.
3. Whether the body currently believes conditions are good, which it signals through GnRH pulse frequency. Sustained low energy availability suppresses GnRH pulse frequency, and the endocrine consequence is measurable rather than moral: LH pulses fall first, sex steroids follow. This is the mechanism behind the pathway's own framing, and it is a physiological state with a read-out, not a character trait.
4. Cortisol timing, which is a curve across 24 hours rather than a value. A flattened diurnal slope, high in the evening and low in the morning, is what the tired-but-wired description reports, and it suppresses gonadotropin output at the hypothalamus. A single 9 am cortisol cannot see a slope, which is why 4 samples across a day earn their cost here.
5. Two blood tests that are commonly the entire explanation, and both are hormone receptor problems. Prolactin and thyroid. Both are one draw, both are frequently missed, and both produce a loss of desire that is indistinguishable by symptom from the psychological version.

The order to run these in, and what has to be true first

Read the prescription list, then fix the sleep, then measure, and only then buy. Three of the 4 commonest causes are free to identify.

1. Go through everything on the repeat script with the prescriber before anything else, because the class effect runs to 70%. The classes with the strongest signal are serotonergic antidepressants Montejo 2001, 5-alpha-reductase inhibitors, opioids, some antihypertensives and antipsychotics. This step costs 1 appointment and can end the whole question, and it is not a step this site can take for anybody.
2. Treat insomnia as the condition it is, with an odds ratio of 3.28 behind the treatment. Across 37 studies of cognitive behavioral therapy for insomnia, 36.0% of patients reached remission against 16.9% of controls, a pooled odds ratio of 3.28 (95% CI 2.30 to 4.68, P<0.001) Wu 2015. That is a larger effect than anything sold for sleep, and snoring with witnessed apneas is a sleep study rather than a supplement.
3. Then one draw, in the morning, before 10 am. Total Testosterone with Free Testosterone and SHBG (Sex Hormone-Binding Globulin), Prolactin, TSH (Thyroid-Stimulating Hormone) with Free T4 (Thyroxine), and Ferritin, because iron deficiency produces fatigue and low desire together and is the cheapest thing on the list to fix.
4. Then the cortisol layer, where the human data is smallest but is a 27.9% number. Ashwagandha at 300 mg twice daily of a root extract lowered serum cortisol by 27.9% against placebo over 60 days in 64 adults Chandrasekhar 2012, and the same class of extract improved sleep onset latency and efficiency in a separate insomnia trial Langade 2019. Withanolides are the proposed active fraction and standardization is the variable that decides whether a given product is the one that was studied.
5. Rhodiola, L-Theanine, Magnesium and Phosphatidylserine are the arousal-tone layer, and two of them act at a receptor rather than on a hormone. Theanine raises alpha power and is a structural analog of glutamate with affinity for the glutamate transporters, magnesium is an NMDA receptor channel blocker at physiological concentrations, and phosphatidylserine has been argued to blunt the cortisol response to acute stress. None of these is a libido drug; they are conditions-improving agents acting over 4 to 8 weeks on a permissive system.
6. Maca and Saffron are the two botanicals with trials specifically in drug-associated sexual dysfunction, which is a narrower and more useful claim than a general libido one. Oxytocin and Selank act on the affiliative and anxiolytic side; oxytocin is a nonapeptide with a plasma half-life of a few minutes, which is the central problem with every route it is offered by.
7. Sleep Stack is a convenience for step two and belongs after the behavioral work rather than instead of it, because a sedative that produces sleep without treating the conditioned arousal stops working at the point it is discontinued.

What gets bought for this that cannot move it

Testosterone does not override serotonin, and 59.1% is the reason. If a serotonergic agent is producing the effect, raising androgen adds a second variable without removing the first, and the response is usually a small improvement that is indistinguishable from expectation. The published separation between agents is large Montejo 2001, which means the highest-value move is a conversation about the specific molecule rather than an addition to it.

Adaptogens cannot outrun an apnea. Intermittent nocturnal hypoxia fragments sleep architecture and suppresses the nocturnal testosterone rise that depends on consolidated sleep. A cortisol-lowering botanical taken against that is treating the downstream number while the upstream event repeats forty times an hour, and the scale of the underlying problem is not small Benjafield 2019.

The category that fails structurally is anything peripheral, because the receptor being addressed is in the wrong organ. This pathway is about wanting, and wanting is generated centrally by 2 named neurotransmitter systems. A vasodilator improves the hydraulics of an event that is not being initiated, which is why the commonest disappointed purchase in the whole libido goal is a PDE5 inhibitor bought for a desire problem.

And if the problem is that the equipment does not work rather than that the interest is absent, this is the wrong page. Vascular & erectile function is the hemodynamic pathway and is also a cardiovascular warning worth taking seriously. If desire is present and the hormonal substrate is the question, Hormonal substrate — testosterone, estrogen, prolactin, thyroid is the router. If the description is closer to nothing feeling rewarding rather than sex specifically, that is Serotonergic and it is a different conversation.

How you would know it was working, on a real read-out and a real timescale

The prediction this page makes is a strong one and it is easy to check: if conditions were the cause, desire returns before any hormone number changes. An improvement at 4 weeks with an unchanged Total Testosterone is the expected result, not a confusing one.

• Total Testosterone with Free Testosterone and SHBG (Sex Hormone-Binding Globulin) at 8 to 12 weeks, on a morning draw. These are here as a floor check rather than as a target: below roughly 250 to 300 ng/dL the conversation changes, and above it a further rise is not what limits desire. SHBG is on the list because it moves with thyroid status, insulin and alcohol, and it changes the free fraction without changing the total.
• Prolactin once, drawn without exercise or nipple stimulation beforehand. Prolactin is stress-responsive and pulsatile, and a single high value on a difficult venipuncture is common enough that the correct next step is a repeat rather than a scan. Macroprolactin, a biologically inactive immunoglobulin complex, is prevalent enough among raised results to be worth excluding Sharma 2021.
• TSH (Thyroid-Stimulating Hormone) with Free T4 (Thyroxine) once. Both hyper- and hypothyroid states suppress desire through a nuclear receptor, and thyroid status also moves SHBG, so an abnormal thyroid produces two findings on this panel from one cause.
• Cortisol (AM) as a curve rather than a point, if the description is tired-but-wired. A single morning value cannot report a flattened slope across 24 hours, and the slope is the finding. Adrenal, cortisol rhythm & stress-driven fatigue sets out how that measurement has to be collected for it to mean anything.
• Ferritin at 12 weeks if it was low. Restored iron stores change fatigue first and desire second, and the ordering is itself informative: desire that improves without fatigue improving was probably not an iron story.

What will fool you. Desire is context-dependent to a degree that makes any 4 week self-assessment unreliable, because a holiday and a deadline move it more than most interventions do. Alcohol acutely disinhibits and chronically suppresses gonadotropin release, so a good night out is not evidence. And ashwagandha's trials are on standardized root extracts at specified withanolide content Chandrasekhar 2012, so a different extract at the same milligrams is not the same intervention.

Sources read for these sections

• Montejo AL. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Journal of Clinical Psychiatry 2001;62 Suppl 3:10-21 · PMID 11229449
• Leproult R. Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA 2011;305(21):2173-74 · PMID 21632481
• Wu JQ, et al. Cognitive Behavioral Therapy for Insomnia Comorbid With Psychiatric and Medical Conditions: A Meta-analysis. JAMA Internal Medicine 2015;175(9):1461-72 · PMID 26147487
• Benjafield AV. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respiratory Medicine 2019;7(8):687-698 · PMID 31300334
• Chandrasekhar K, et al. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine, 2012 · PMID 23439798
• Langade D, et al. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Insomnia and Anxiety: A Double-blind, Randomized, Placebo-controlled Study. Cureus, 2019 · PMID 31728244
• Sharma LK, et al. Prevalence of Macroprolactinemia in People Detected to Have Hyperprolactinemia. Journal of Laboratory Physicians 2021 · PMID 34975255